Category: Uncategorized

  • Michael Wang, A Pivotal Time in the Nicotine Industry

     


     

    There are these rare moments in the life of a company when the world catches up to where you’ve been heading.

     


    For Ispire, that moment is now.

    Global regulation is no longer a headwind. It’s a clear filter separating companies that were built for compliance from those that would rather go around it.

    We only need to look at the colossal, illicit global vaping market to know that things have gone too far.

     

    – A lack of adequate technology solutions preventing underage use has resulted in US regulators not being willing to approve flavored e-cigarettes.
    – And yet, unprecedented demand for flavored e-cigarettes has driven consumers to unregulated, illicit products with documented or potentially harmful ingredients.
    – Furthermore, businesses that have been trying to do the right thing have been suffering from the oversized and oversaturated illicit market.

     

    During a challenging time for worldwide consumers and regulators, the team at Ispire Technology has been working on a range of advanced technologies that can solve the industry’s pain points.

     


    Compliance and Point-of-Use Age-Gating Technology

    Two years ago, we made a deliberate choice to hold the ‘compliance’ high ground: no illegal import channels, no regulatory arbitrage, no short-term volume at the cost of long-term credibility and compliance.

    The journey wasn’t easy. The overwhelming illicit market rewarded the wrong behaviors for longer than it should have. But the landscape is shifting:

     

    – Regulators have begun large-scale enforcement and seizure of illicit products. The companies that did not cut corners are now on more solid ground.
    – Regulators are now equipped with better tools to enforce their policies.
    – Newly published FDA Guidance for the industry on flavored e-cigarettes states that point-of-sale age verification is not sufficient to prevent underage use of e-cigarettes. That point-of-use, on-device age verification is the only way to unlock the flavored e-cigarette market.

     

    Ispire Technology leads the field in these critical areas. The growing demand for age-gating at the point of use suddenly places Ispire Technology at the very forefront of shaping the approval and compliance of a new generation of responsible nicotine use.

     


     

    FDA & IKETECH

    The FDA’s new guidance on flavors and age verification, alongside the UK’s landmark Vapes Bill, are not isolated policy moments.

    They are convergent signals of a global shift: the category is moving toward traceability, age-gating, and accountability by design. Regulators on both sides of the Atlantic are demanding what we have already built.

     


     

    Our integrated age-verification architecture, essentially the IKE platform.

    “This wasn’t a marketing decision. It was an infrastructure decision.”

    “The market is now legislating toward it. That’s not luck. That’s positioning.”

     


     

    Since late 2025, we have received an increasing number of inbound inquiries or proposals from tobacco brands regarding the leading-edge point-of-use age-gating technology developed by our joint venture, IKETECH.  These interests have led to varying stages of discussions, including joint development agreements and technology licensing agreements, both for the US market and for international markets.

    We expect this leading-edge technology not only to generate rapid revenue growth for the joint venture but also to expand Ispire’s manufacturing partnerships with those brands directly.

     


    Malaysia: The Strategic Advantage

    Our nicotine manufacturing license at our Malaysia-based manufacturing hub provides a key strategic advantage as the world’s supply chains are further tested by geopolitical uncertainty.

    These factories are further evidence that Ispire can operate compliantly at scale in regulated markets, with a significant point of differentiation.

     

    – China’s introduction of a series of regulatory tightening measures (in both e-cigarettes and nicotine pouches), coupled with the rising costs within China’s vape manufacturing sector (including the recent imposition of 13% VAT on e-cigarette exports), is reshaping global competitive dynamics in favor of our Malaysian operations.
    – Our all-new Malaysian footprint gives us structural advantages in cost, compliance, and continuity that competitors building exclusively within China are only now beginning to recognize, as government regulation and taxation increase.

     

    This past year, we have received numerous inbound proposals for products to be manufactured in our Malaysian factories.  We have been carefully evaluating the opportunities while we built out our production lines.  Production for several brands will commence in calendar Q2 of 2026, with more customers to be added over the remainder of 2026 and 2027.

    We are proud to note that our Malaysian manufacturing capabilities are now even serving Chinese export brands, which is a meaningful reversal of the traditional supply chain dynamic and a direct reflection of our compliance foresight.

     


    Atomizer Technologies that Matter

    Proprietary vaping technology has not been far from our minds either, with our latest Silica Heat TM platform representing a leap forward in flavor delivery, performance consistency, and most importantly, consumer safety.

    This isn’t an incremental improvement; it is a key leap forward for the industry in 16 years.

     

    – Ispire Technology continues to lead on hardware innovation and, in addition to keeping pace with category trends, has increased our investment in precision engineering to improve performance-critical and regulated channel applications that reflect a total commitment to users who demand reliability, not novelty.
    – For those in adjacent wellness and functional categories, where the bar for product integrity is even higher, our engineering capabilities are increasingly relevant.

     

    We are watching these spaces carefully and building our IP portfolio accordingly.

    We have also been in careful and serious discussions with leading tobacco brands on licensing the Silica Heat technology, as well as on a manufacturing partnership using such a technology.

     


    A More Responsible Future 

    The consumer nicotine category is entering its most consequential regulatory and technological transition to date.

    The companies that define the next decade will not be the ones reacting to legislation.

    They will need products, systems, and supply chains that were already built to shape the future today, and Ispire Technology is one such company.

    We have the licenses, technology, manufacturing infrastructure, and compliance architecture to lead, not follow.  Driving a more controlled, competitive, accountable, and ultimately more sustainable Nicotine category is our goal.

     


    “We are built for this. We’re ready for what comes next, and we welcome all of you to be a part of our exciting journey.”

     

    Michael Wang

    Chief Executive Officer, Ispire Technology


     

     

    *SilicaHeat, Silca Air, Silica X are all trademarks for Ispire Technology, IKE is a 40% owned joint venture of Ispire Technology.  Ispire Malaysia is a wholly owned subsidiary of Ispire Technology. Aspire and associated companies are all subsidiaries of our group of companies.

  • Ispire Highlights Economic Impact of New FDA Guidance on Flavored ENDS Unlocking a $50 Billion Market and Driving Significant Potential Asset Value

    FDA establishes first-ever framework for flavored ENDS, recognizing device level age verification as a regulatory requirement

    FDA guidance unlocks an estimated $50 billion total addressable market, allowing companies to lawfully transition the 70% illicit flavored vape market into a compliant ecosystem

    Ispire’s 40%-owned IKE Tech joint venture is positioned to generate $5 million to $20 million in annual recurring SaaS revenue per customer in the US

    Based on conservative SaaS metrics, even a limited number of customers could potentially value the IKE joint venture in the hundreds of millions, dramatically increasing Ispire’s book value

    Ispire-backed IKE Tech was first to file component PMTA for continuous, blockchain-enabled age-gating technology
    LOS ANGELES, March 16, 2026 /PRNewswire/ — Ispire Technology Inc. (“Ispire” or the “Company”) (NASDAQ: ISPR), a trailblazer in vaping technology and precision dosing, today highlighted the massive economic value and multi-billion-dollar market opportunity created for its shareholders by the U.S. Food and Drug Administration’s (FDA) newly issued draft guidance outlining evidentiary expectations for Premarket Tobacco Product Applications (PMTAs) for flavored electronic nicotine delivery systems (ENDS).

    The FDA’s guidance effectively unlocks a $50 billion total addressable market by providing a lawful pathway for flavored vapes, which currently consist largely of illicit products. Ispire’s 40%-owned joint venture, IKE Tech LLC (“IKE Tech” or “IKE”), is uniquely positioned to capture this market. IKE’s recurring SaaS revenue model is expected to generate $5 million to $20 million annually per customer. Management believes that securing even a limited number of customers could value the IKE joint venture in the hundreds of millions, creating a highly valuable asset on Ispire’s balance sheet.

    The guidance marks the first time the FDA has formally outlined a framework for evaluating flavored ENDS products, recognizing that device-level access technologies — or Device Access Restrictions (DAR) — may factor into whether a product meets the “appropriate for the protection of public health” (APPH) standard for PMTA authorization.

    The draft guidance highlights DAR technologies such as biometric authentication, geofencing, and continuous age verification as potential safeguards designed to prevent underage use of ENDS devices. FDA also emphasizes that traditional safeguards such as local age restrictions and point-of-sale verification that do not directly prevent youth use may not, when employed alone, sufficiently reduce youth use.

    “We believe this guidance represents a major step toward a technology-enabled regulatory framework for the vapor category,” said Michael Wang, Co-Chief Executive Officer of Ispire. “FDA’s recognition of Device Access Restrictions validates our long-held position that continuous, device-level age verification can protect youth while preserving adult choice.”

    Ispire has long advocated for technology-driven youth prevention solutions. Through IKE, a joint venture that includes Ispire as a founding partner, the Company has supported the development of advanced identity and authentication systems designed to control device access directly at the point of use, rather than solely at the point of sale.

    In 2025, IKE Tech submitted the first-ever component PMTA for a standalone, interoperable age-verification technology designed for integration across ENDS devices. The platform combines Bluetooth Low Energy (BLE) chips, biometric authentication, and blockchain-secured identity verification to ensure that only verified adult users can activate a device. In a multi-center Human Factors Validation Study submitted with the PMTA, the IKE age-gating technology achieved:

    • 100% effectiveness in preventing device activation by underage users
    • 100% accuracy in demographic verification
    • User error rates below 1%, underscoring ease of use for adults
    • 91% user satisfaction with app simplicity and functionality
    • In addition to age verification, the IKE technology platform can also support product authentication and anti-counterfeiting capabilities, helping manufacturers and regulators identify illicit or counterfeit devices that bypass regulatory safeguards, evade taxes, and undermine consumer safety.

    Economic Opportunity and Market Impact

    The FDA’s draft guidance may immediately unlock access to a multi-billion-dollar segment of the U.S. vapor market. With flavored products representing a substantial portion of consumer demand, the agency’s recognition of DAR creates a potential pathway for compliant manufacturers to compete in segments previously dominated by illicit trade.

    Industry estimates suggest that approximately 70% of the current U.S. vape market consists of illicit or unauthorized products. Data suggests that the total U.S. vapor market is currently around $50 billion annually, when accounting for hard-to-track illicit and unauthorized products. IKE’s technological solutions will allow companies to address this massive total market.

    Over recent months, IKE Tech is actively working with large tobacco companies, leading independent brands, and several of the largest e-cigarette manufacturers to evaluate integration of its technology into flavored PMTA submissions, while also receiving strong inbound interest from manufacturers seeking to bring compliant flavored ENDS products to the U.S. market.

    Following the FDA’s guidance, Ispire believes this framework could also influence global regulatory policy, with several major markets potentially moving toward mandating device-level age verification for ENDS products.

    IKE’s business model is structured as a recurring compliance technology platform, generating SaaS revenue from manufacturers integrating the system into their devices. Each customer using the technology is expected to generate approximately $5 million – $20 million in annual recurring SaaS revenue, alongside recurring per-device hardware sales or firmware licensing fees. Even a limited number of authorized flavored ENDS products incorporating IKE’s technology could create significant enterprise value for the platform.

    About IKE Tech LLC

    IKE Tech LLC is a joint venture comprised of Ispire Technology Inc., Touch Point Worldwide Inc. d/b/a Berify, and Chemular Inc. Founded in 2024, IKE Tech is building the identity layer for the physical world. With patented technologies spanning blockchain authentication, secure BLE communication, and AI-enhanced access control, IKE powers secure, user-centric device interactions across regulated and high-risk sectors.

    IKE’s System-on-a-Chip allows manufacturers to embed customizable, interoperable access controls into vapor devices — ensuring authorized adult use and preventing youth access through real-time mobile and biometric authentication. Visit www.iketech.com.

    About Ispire Technology Inc.

    Ispire is engaged in the research and development, design, commercialization, sales, marketing and distribution of branded e-cigarettes and cannabis vaping products. The Company’s operating subsidiaries own or license more than 400 patents worldwide. Ispire’s branded e-cigarette products are marketed under the Aspire name and are sold worldwide (except in the U.S., People’s Republic of China and Russia) primarily through its global distribution network. The Company also engages in original design manufacture (ODM) relationships with e-cigarette brands and retailers worldwide. The Company’s cannabis products are marketed under the Ispire brand name primarily on an ODM basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware in the US, Europe and South Africa and it recently commenced marketing activities and customer engagement in Canada and Latin America. For more information, visit www.ispiretechnology.com or follow Ispire on Instagram, LinkedIn, Twitter and YouTube.

    Forward Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”) as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company’s future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “would,” “could,” “seek,” “intend,” “plan,” “goal,” “project,” “estimate,” “anticipate,” “strategy,” “future,” “likely” or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company’s strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: whether the Company may be successful in re-entering the U.S. ENDS market; the approval or rejection of any PMTA submitted by the Company; whether the Company will be successful in its plans to further expand into the African market; whether the Company’s joint venture with Touch Point Worldwide Inc. d/b/a/ Berify and Chemular Inc. (the “Joint Venture”) may be successful in achieving its goals as currently contemplated, with different terms, or at all; the Joint Venture’s ability to innovate in the e-cigarette technology space or develop age gating or age verification technologies for nicotine vaping devices; the Company’s ability to collect its accounts receivable in a timely manner; the Company’s business strategies; the ability of the Company to market to the Ispire ONE™; Ispire ONE™’s success in meeting its goals; the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of its products on the markets; the Ispire ONE™ proving to be safe; and the risk and uncertainties described in “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Cautionary Note on Forward-Looking Statements” and the additional risk described in Ispire’s Annual Report on Form 10-K for the year ended June 30, 2025 and any subsequent filings which Ispire makes with the SEC. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in this press release relate only to events or information as of the date on which the statements are made in this press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by applicable law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.

    IR Contact:
    Phil Carlson
    +1-212-896-1233
    ispire@kcsa.com

    PR Contact:
    Ellen Mellody
    +1-570-209-2947
    ispire@kcsa.com

    SOURCE Ispire Technology Inc.

     

  • Ispire Technology Inc. Announces Participation in the 12th Annual MJBizCon Expo

    Los Angeles, November 21, 2023 – Ispire Technology Inc. (“Ispire” or the “Company”) (NASDAQ: ISPR), a leader in the development and commercialization of vaping technology and precision dosing, announced that the Company will be participating in the 12th annual Marijuana Business Conference and Cannabis Expo (“MJBizCon”), taking place from Tuesday, November 28, 2023 through Friday, December 1, 2023 at the Las Vegas Convention Center.

    Members of Inspire’s senior management team, including Co-Chief Executive Officer Michael Wang, Chief Financial Officer Daniel Machock, Chief Operating Officer Ted Rouhani, Chief Legal Officer Steven Przybyla and Head of Product Greg McNiel, will be hosting meetings during MJBizCon.

    Ispire’s team will also showcase its award winning Ispire ONE™ systems as well as its complete line of cartridges, disposables, batteries and dabbing products at booth #8018. MJBizCon runs from 10:00 a.m. PST to 6:00 p.m. PST on Tuesday, Wednesday and Thursday, and from 10:00 a.m. PST to 3:00 p.m. PST on Friday.

    For more information or to schedule a one-on-one meeting with Ispire’s management, please contact Ispire’s Investor Relations at ir@getispire.com.

    About Ispire Technology Inc.

    Ispire is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The Company’s operating subsidiaries own or license more than 200 patents received or filed globally. Ispire’s tobacco products are marketed under the Aspire brand name and are sold worldwide (except in the U.S., People’s Republic of China and Russia) primarily through its global distribution network. The Company’s cannabis products are marketed under the Ispire brand name primarily on an original design manufacturer (ODM) basis to other cannabis vapor companies. Ispire sells its cannabis vaping hardware only in the U.S., and it recently commenced its marketing activities in Canada and Europe. For more information, visit www.ispiretechnology.com or follow Ispire on Instagram, LinkedIn, Facebook, Twitter and YouTube.

    Forward Looking Statements

    This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended (“Securities Act”) as well as Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended, that are intended to be covered by the safe harbor created by those sections. Forward-looking statements, which are based on certain assumptions and describe the Company’s future plans, strategies and expectations, can generally be identified by the use of forward-looking terms such as “believe,” “expect,” “may,” “will,” “should,” “would,” “could,” “seek,” “intend,” “plan,” “goal,” “project,” “estimate,” “anticipate,” “strategy,” “future,” “likely” or other comparable terms, although not all forward-looking statements contain these identifying words. All statements other than statements of historical facts included in this press release regarding the Company’s strategies, prospects, financial condition, operations, costs, plans and objectives are forward-looking statements. Important factors that could cause the Company’s actual results and financial condition to differ materially from those indicated in the forward-looking statements. Such forward-looking statements include, but are not limited to, risks and uncertainties including those regarding: the Company’s ability to collect its accounts receivable in a timely manner, the Company’s business strategies, the ability of the Company to market to the Ispire ONE™, Ispire ONE™’s success if meeting its goals, the ability of its customers to derive the anticipated benefits of the Ispire ONE™ and the success of their products on the markets; the Ispire ONE™ proving to be safe, and the risk and uncertainties described in “Risk Factors,” “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” “Cautionary Note on Forward-Looking Statements” and the additional risk described in Ispire’s Annual Report on Form 10-K for the year ended June 30, 2023 and any subsequent filings which Ispire makes with the U.S. Securities and Exchange Commission. You should not rely upon forward-looking statements as predictions of future events. The forward-looking statements made in the press release relate only to events or information as of the date on which the statements are made in the press release. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events except as required by law. You should read this press release with the understanding that our actual future results may be materially different from what we expect.